Johnson & Johnson Infant Tylenol Settlement – Are You Eligible To File A Talc Lawsuit?

You May be Entitled to Significant Compensation Johnson & Johnson infant tylenol settlement. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

J&J’s proposed talc settlement will provide $440 million US state AGs. Johnson & Johnson Infant Tylenol Settlement .

Johnson & Johnson (JNJ.N) has put the amount of $400 million for resolving U.S. state consumer protection actions as part of a broad $8.9 billion effort to settle claims that its Baby Powder as well as other talc product causes cancer. Johnson & Johnson infant tylenol settlement.

J&J affiliate LTL Management filed a bankruptcy plan in New Jersey late on Monday that describes how the company intends to pay different types of cancer sufferers in bankruptcy settlement. Johnson & Johnson infant tylenol settlement. J&J has declared that its Talc products are safe, and will not cause cancer. It’s trying for an additional time to conclude more than 38,000 lawsuits brought in bankruptcy and stop new cases from arising in the near future.
LTL’s bankruptcy plan would pay $400 million to a separate trust for lawsuits filed with state attorneys general claiming that J&J had violated state unfair business practices and consumer protection laws through misleading consumers about the security of its talc-based products.

Several states had begun consumer protection lawsuits against J&J prior to LTL’s bankruptcy filing prevented those investigations from progressing in 2021. Johnson & Johnson infant tylenol settlement. New Mexico and Mississippi had already filed suits against Johnson & Johnson before then and the states of Arizona, Maryland, North Carolina, Texas and Washington had issued subpoenas or civil investigative demands, according to LTL’s court filings.

 

 

New Mexico and Mississippi have decided to declare LTL’s bankruptcy unfinished along with cancer sufferers as well as the U.S. Justice Department’s bankruptcy watchdog. argue that a profit-making company like J&J cannot benefit from bankruptcy protections designed for people with debt problems.
The company’s initial attempt to resolve the bankruptcy cases was dismissed after similar arguments. The U.S. appellate court determined the LTL was not in “financial distress” and thus not eligible of bankruptcy protection. Johnson & Johnson infant tylenol settlement. LTL declared bankruptcy a second time within two hours of the decision to dismiss, arguing that the second bankruptcy was different in that it had less money available and more support for a settlement.

New Mexico and Mississippi said in their motion to dismiss LTL’s bankruptcy renewal violates the law enforcement powers of the state by seeking to unilaterally limit LTL’s liability to state consumer protection measures.

 

Johnson & Johnson Infant Tylenol Settlement

LTL’s recent filings also provided more details on how the company plans to evaluate and settle cancer claims should the bankruptcy plan be approved.

The most significant payments under the settlement would be $500,000 for patients diagnosed with terminal mesothelioma before age 45. Johnson & Johnson infant tylenol settlement. The second payment would be $260,000 for those who have been diagnosed with cancer of the ovary before age 45.

The proposed settlement applies discounts depending on the type and severity of cancer, an individual’s age, history of the use of talc, and other aspects. Johnson & Johnson infant tylenol settlement. For instance the case of a woman who used daily talc products, had a family history of ovarian cancer, and was diagnosed with an ovarian cancer stage II at the age of 55 might qualify to receive a payout of $21,125 under the plan.

Judge ordains J&J and talc opponents take part in settlement talks.

After another round of hearings in Johnson &Johnson’s attempt to employ a Texas Two Step bankruptcy strategy to settle talc lawsuits and federal bankruptcy judge Michael Kaplan has ordered the company and those opposed to the move to conduct negotiations to settle the matter, Bloomberg reports.

The second time it attempted to file for bankruptcy for LTL Management, a subsidiary created by J&J to hold the claims–the company made a settlement offer of $8.9 billion. Johnson & Johnson infant tylenol settlement. While one firm representing plaintiffs supports the settlement, a different group is opposed to the offer.

The previous week, the opposition group, called the Official Committee of Talc Claimants and urging the bankruptcy court to disqualify the petition asserting that LTL can not be considered financially distressed.

“The filing is a desperate and legally deficient attempt by a tiny number of law firms to prevent claimants from voting on the resolution, which the vast majority of claimants approve of,” J&J’s litigation chief Erik Haas, said in an announcement. Johnson & Johnson infant tylenol settlement. “The law firms behind the filing are pursuing financial interests which conflict with, contradict and are in opposition to the interests that their customers. We will be submitting an appeal an appeal to the appellate court.”

Johnson & Johnson infant tylenol settlement. Clay Thompson, a lawyer for MRHFM that has more than 80 mesothelioma victims who have filed lawsuits against J&J, said that J&J’s second bankruptcy effort is likely to fail.

“J&J issue press releases about how great its plan is, while demanding that plan details–including what individuals with illnesses would receive — be kept private,” Thompson said in an announcement. “What does the company have to conceal?”

 

 

Kaplan has commanded the parties to devise a second arrangement plan under the supervision from two mediators.

On February 20, 2022 Kaplan stated that J&J’s use of Chapter 11 to hasten a settlement that would relieve the company from the thousands of lawsuits concerning its talcum products.

In January of this year, an appeals court in the United States overturned the decision, ruling that the business could not be considered in “financial difficulty.”

After J&J’s challenge the U.S. Supreme Court was rejected in April, J&J was granted a second petition for bankruptcy about two hours after. In response, Kaplan froze the lawsuits for 60 calendar days to decide whether or not to accept to file for bankruptcy again.

J&J’s unstoppable profit engine sputters after $6.9B cost of litigation involving talc.

Through Two Chapter 11 attempts, J&J has bought 19 months during which cases have been in limbo. Johnson & Johnson infant tylenol settlement. The company is requesting that claimants vote on accepting their settlement. J&J requires 75% acceptance for the deal to pass.

In addition to the team of talc lawyers who panned the bankruptcy of the company as well, the U.S. Trustee which is a division from the U.S. Department of Justice, also filed an appeal to dismiss LTL’s second bankruptcy case.

In a filing this week, U.S. trustee Andrew R. Vara wrote that the doors of the bankruptcy court remain “open to honest but unfortunate debtors.” These doors “are not accessible to those that lack a legitimate bankruptcy goal or who seek to use the bankruptcy process to hinder or delay their creditors,” Vara continued.

On the other hand, J&J maintains there is no conclusive evidence that its talc products, including its iconic baby powder, can cause cancer. J&J has adopted the products of the market–first to be available in North America in 2020–and the rest of the world this year.

J&J wants to avoid the cost of going to court. J&J has won the majority of cases decided at trial, but some losses have been punishing.
A highly publicized trial in Missouri produced an $4.7 billion verdict against the drugmaker that was later reduced to $2.1 billion after appeals.

Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ talc strategy: report
Overall, J&J has lost nine cases involving talc, which are appealing or settled. In 41 trials 32 ended with winning for J&J, a mistrial or plaintiff verdict that was annulled in appeal. Johnson & Johnson infant tylenol settlement. Additionally, the company in 2020 moved to settle around 1,000 cases worth $110 million. Bloomberg announced at that time.

 

Talcum Baby Powder Ovarian Cancer Lawsuit – Johnson & Johnson Infant Tylenol Settlement

Our lawyers handle the baby powder litigation in all 50 states. The talcum powder lawsuits against Johnson & Johnson have been ongoing for many years. Johnson & Johnson infant tylenol settlement. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in many products, including baby Powder along with Shower to Shower and Shower to Shower, could cause ovarian cancer among some women.

This page provides a J&J update on the talc power litigation and examines how the coming bankruptcy ruling impacts the ultimate settlement amounts in these cases of ovarian cancer.

Have you reached the deadline by which you to start a lawsuit against talcum powder? Many who believe the statute of limitations has run out to file a lawsuit against Johnson & Johnson are wrong. Call us today at 800-553-8082 or get a free and quick case review online.

 

Johnson and Johnson Talcum Powder Lawsuit Update 2023 – Johnson & Johnson Infant Tylenol Settlement

June 2 2023 Update: In the asbestos talc case in California yesterday, technical issues disrupted the opening speech of defense attorneys. Johnson & Johnson infant tylenol settlement. Jurors from home via Zoom and hearing the Johnson & Johnson’s lawyer voice his doubts about the 70s research that claimed asbestos was present in their product prior to the opening was abruptly ended.

The plaintiff was able to introduce the first of their witnesses, Arthur Langer. Langer stated that the presence of other minerals alongside talc is inevitable. He said that his team advised J&J in 1971 of the presence of chrysotile asbestos the company’s talc, albeit in less than 0.1 percent. He also found more asbestos in 1976.

June 1st, 2023 Update: Johnson & Johnson infant tylenol settlement. This is the first court trial that has taken place since J&J has decided to separate its talc section and declaring bankruptcy is an important turning point in the ongoing talc lawsuit controversy. Trial started on Monday in the tragic case of a young, 24-year-old plaintiff, diagnosed with an extremely rare and aggressive form of mesothelioma last year. which lawyers on both sides agree is a harrowing tragedy.

The opening statements exposed the stark differences in each side’s narrative. The plaintiff’s attorney took aim at Johnson & Johnson, alleging the use of misleading techniques in its research practices and throughout the litigation process. The attorney claims that, according to the company attempted to manipulate asbestos’ definition, despite internal documents dating back to between 1978 and 1994 that showed asbestos fibers in the tissues of the plaintiff are part of.

Johnson & Johnson’s precarious $8.9 billion settlement proposal hangs in the balance as we course of this trial. Despite the distinct nature of this mesothelioma-related case and its distinctive issues in comparison to other talcum powder lawsuits, a verdict favoring the plaintiff could be an enormous setback for J&J’s hopes of broad acceptance of their settlement proposal among plaintiffs.

May 31st, 2023 Update: Johnson and Johnson’s bankrupt talc business strongly defended the 2nd Chapter 11 filing in the facing challenges from the talc injury plaintiffs. In an objection submitted to the New Jersey bankruptcy court, the company argued that the case was fundamentally different from the earlier filing. It emphasized the unprecedented commitment of $8.9 billion in settlement from J&J, the largest settlement ever made in an bankruptcy case involving mass torts. Johnson & Johnson infant tylenol settlement. There was no mention of how this amount means it is an equitable settlement. J&J also claimed support from various plaintiffs’ law firms that represent over 600,00 claimants. This is not easy to confirm however it is likely to be incorrect.

May 24 2023 Update: As of Johnson & Johnson’s 2021 bankruptcy filing, the very first trial involving its cosmetic talc products allegedly that contain asbestos is scheduled to start jury selection Monday in California within the Alameda County Superior Court, the most favored location for plaintiffs. Plaintiff claims that mesothelioma was triggered by asbestos exposure resulting from J&J’s products which the company is denying. The trial also involves six retailers accused of selling talc-containing products.

May 22nd, 2023 Update: Lawyers involved in the second J&J talc bankruptcy are disputing who should be appointed to the role of future claims representative. This is which is vitally critical to resolving claims involving talc. Johnson & Johnson infant tylenol settlement. Randi Ellis, a lawyer who is frequently involved in MDLs all over the nation was appointed the claims representative during the first bankruptcy. J&J’s defense group wants Ellis to be appointed to that role and again, but attorneys for the talc plaintiffs are objecting to the claim that Ellis has conflicts of interest that should prevent her from being appointed to that post once more. The conflict stems from the possibility that Ellis was reportedly involved in drafting the hotly disputable second bankruptcy, which raises concerns about her ability to be neutral. In reality, this bankruptcy will likely to be dismissed regardless.

May 17th, 2023 Update: The pretend company J&J formed to settle the talc litigation bankruptcy disclosed to an New Jersey bankruptcy court that they have allocated $400 million to settle the claims made by states accusing the company of deceptive advertising for its talc product. Johnson & Johnson infant tylenol settlement. That’s an $8.5 billion settlement for cancer victims. It’s hard to imagine a scenario where J&J can push the baby powder settlements at these numbers. Although J&J’s $8.5 billion offer might seem like a huge sum at first, it does not look great when you look at the numbers. This settlement proposal – by our rough calculations would not pay victims much more than $100,000 per instance. That’s not enough.

May 15 2023 Update J&J may be in the middle of a suit from an advocacy group that represents cancer patients. Johnson & Johnson infant tylenol settlement. The group contends that J&J deliberately withdrew a $61.5 billion contract for funding in conjunction with its affiliate, LTL Management LLC, to simulate financial distress and verify the unit’s Chapter 11 bankruptcy filing. The group claims that this move amounts to a fraudulent transfer of the right to compensation for victims. They are planning to study J&J’s actions after the announcement of the denial of LTL’s first bankruptcy suit.

May 10, 2023 Update: Next week next week, it is expected that the U.S. Bankruptcy Court in New Jersey will hear oral arguments on a petition to dismiss the second bankruptcy petition filed by J&J subsidiary LTL Management. In the meantime, however, it has approved an Order that requires both parties to take part in a new settlement mediation in the hope that it will be possible to reach a global settlement agreement come to fruition.

May 5th 2023 Update: The talc supplier Whittaker, Clark & Daniels filed for Chapter 11 bankruptcy due to numerous lawsuits alleging its talc products caused cancer through asbestos exposure. Johnson & Johnson infant tylenol settlement. Over 2,700 people have sued the firm and it has been paying $1 million per month to defend its legal position. The company’s recent $29 million verdict in South Carolina forced it to apply for bankruptcy protection and argue for an equitable distribution of assets between the claimants of talc instead of being taken over in the hands of the receiver. Other talc suppliers have also filed for bankruptcy due to legal proceedings.

May 4, 2023 Update U.S. bankruptcy judge Michael Kaplan has directed Johnson & Johnson to relaunch talks on settlement with lawyers who turned down the company’s proposed $8.9 billion settlement offer. The court in Trenton, New Jersey yesterday, the parties appeared in court to discuss the next steps to take in another bankruptcy proceeding and Judge Kaplan was pushing for more settlement discussions.

This is the way to settle these claims for J&J. The baby powder settlement is likely to be made. Johnson & Johnson infant tylenol settlement. However, it will require additional money – perhaps billions of dollars of Johnson & Johnson.

Lawyers are divided over whether to take the proposal or not and not all clients view the issue the same way their lawyer sees it. Second bankruptcy cases are likely to be a failure the judge Kaplan has scheduled a hearing in June to decide if he will close the case for the third time.

May 3, 2023 Update The group of cancer patients who have sued Johnson & Johnson (J&J) requested an order from they request that the Third Circuit halt the bankruptcy filed by J&J subsidiary LTL Management, claiming it is a bid to stop the litigation surrounding talc-based products. The group of talc claimants filed a motion on Tuesday, asking the Third Circuit to consider their case and to send it back to a lower court, with instructions to discharge the bankruptcy. Johnson & Johnson infant tylenol settlement. They also asked that the halted tort litigation against J&J should be permitted to continue.
LTL requested Chapter 11 protection once again after its first bankruptcy filing was denied in the Third Circuit earlier this year, offering a $8.9 billion settlement. The committee argues that the recent ruling, which allows LTL’s second Chapter 11 to continue, while also halting trials against J&J and J&J, requires the immediate Third Circuit review. The US Trustee requested the New Jersey bankruptcy court dismiss the LTL bankruptcy case. J&J’s vice president for global litigation Erik Haas, was quoted by Bloomberg declaring that J&J intends to file a statement in the appeals court, declaring the filing a “desperate and legally insufficient attempt” by a handful of law firms who have conflicting financial interests.
May 1st 2023 Update: One frequently asked question is how plaintiffs and their attorneys turn on $8.9 billion. Of course, it’s quite a sum. But there are plenty of victims. Johnson & Johnson infant tylenol settlement. These are actually a good claims for plaintiffs. We were reminded of this recently when two talc cases resulted in big verdicts for plaintiffs. In February the mesothelioma case involving talcum powder trial in Oregon ended in a verdict that was $18.1 million. In the same month, a different mesothelioma-related talc case went to hearing on the other side of South Carolina and resulted in a verdict of $29 million for the plaintiff. It was the same defendant as in these cases: Whittaker, Clark & Daniels Inc. which is one of the top suppliers of talc in the U.S.
April 30th, 2023 Update: When J&J initially attempted to pull the litigation over talcum powder into bankruptcy, it came with an offer to reserve $2 billion to settle the case. It was a ridiculously small amount. There was no one among the talc victims who agreed with the proposal. However, this time, J&J has increased the offer to $8.9 if the talc plaintiffs will allow a bankruptcy settlement and they have the support of a large part of the talc-related plaintiffs and their lawyers. Johnson & Johnson infant tylenol settlement. However, 75% of plaintiffs in the talc category, which is required for bankruptcy plan approval is a difficult road since there are so many lawyers with massive inventories of baby powder-related lawsuits, opposed to the settlement.

What can be done to end the impasse? More billions.
April 25 2023 Update Talc patients have sought a court order to disqualify their Chapter 11 case filed by LTL Management LLC, a absurdly-made-up Johnson & Johnson subsidiary, insisting that the company is not financially troubled. LTL requested Chapter 11 to settle tens of thousands of claims that J&J’s baby-powders caused cancer. Johnson & Johnson infant tylenol settlement. LTL was denied Chapter 11 in January. 3rd Circuit dismissed its first Chapter 11 case in January in a ruling that said the company wasn’t eligible for bankruptcy relief since it was unable to demonstrate financial difficulties.

The claimants argue that LTL’s second Chapter 11 case is an misuse of the bankruptcy system, and that the case is being handled in bad good faith. J&J claims the bankruptcy settlement receives “significant backing” from firms representing around 60,000 plaintiffs. It is fair to say that lawyers representing plaintiffs and the victims are split over their disagreement over the $8.9 billion settlement offer.

April 21st, 2023 Update: A bankruptcy judge decided that Johnson & Johnson must face new lawsuits alleging that the firm sold a baby powder that contained a chemical that causes cancer. Even though trials for Talc lawsuits are suspended for a minimum of 60 days but new lawsuits can be filed, and lawyers will begin preparing their cases. Johnson & Johnson infant tylenol settlement. The judge expressed his doubts about J&J’s attempt to revive its strategy by filing another bankruptcy case.

April 13 2023 update: the major announcement is an $8.9 billion over 25 years settlement offer. Lawyers representing cancer victims involved in the MDL Class Action have promised to fight the settlement along with talc claimants. Why? They feel it’s too little money for the 70,000 victims who have cancer. Johnson & Johnson infant tylenol settlement. These lawyers argue that J&J should negotiate a bigger settlement or even litigate individual claims if the most recent bankruptcy is thrown out.

However, there is a second lawyer group that isn’t part of the leadership of that class action. The lawyers collectively have accumulated many thousands of cases. They want to settle for what is believed to be less than the victims deserve. Their argument seems to be twofold. The first is that they claim the settlement – about an average of $100,000 per plaintiff is fair.

This argument isn’t easy to present. The second argument is more teeth: victims can be no longer patient and demand their money today.

April 12 2023 Update: Many are seeking out how J&J is able to file for bankruptcy again. The answer is complex and complex. Let’s try to simplify it simply.
Johnson & Johnson asserts that bankruptcy is the only option to address both present and future talc litigations in a definitive manner. It believes it can pay less if there is an element of bankruptcy that puts pressure to settle. Johnson & Johnson infant tylenol settlement. In a quest to cover 400 years of American history, the company claims that bankruptcy benefits all parties by distributing settlements more fairly and efficiently than trial courts, in which some litigants receive substantial awards while others receive nothing.

The main thrust in this 3rd Circuit decision was this is not a matter of the profit-making company that has an affiliate to accept the legal responsibility and declare bankruptcy, which is what Congress considered when it was drafting the Bankruptcy Code. However, it also stated that the subsidiary was not in financial distress because J&J promises unlimited funding.
Thus, J&J decided to go with the unlimited funding aspect of the holding but did not pledge to fund unlimited lawsuits. The company says that its modified financing arrangements with its subsidiary address concerns of the appeals court while offering funds to pay claims. It’s as if giving victims less money will solve the overall issue.

Lawyers representing cancer victims who are against the agreement argue the agreement with what is the legal argument. Johnson & Johnson infant tylenol settlement. They counter with legal nonsense: J&J fraudulently transferred $50 billion in assets to LTL Management to circumvent the appeals court’s previous decision. Hyperbole is not exempt attorneys representing the victims claim this the biggest “fraudulent transfer in United States history.”

Despite all the legal jargon, J&J does not really believe this bankruptcy will be able to last. But it is a way to push for this $8.9 billion settlement through and maintain the pressure on plaintiffs.

April 10, 2023 Update Bloomberg provides an insightful report on a brand new law in New Jersey that is shedding new light on the funding of litigation in the baby powder suit for class actions. Litigation funders Virage Capital Management and TRGP Capital invested in hundreds of lawsuits that were brought against Johnson & Johnson (J&J) on behalf of talc products. They exchanged in exchange for a portion of profits. J&J is now offering to pay $8.9 billion to settle lawsuits.

The involvement of the funders is public knowledge because of a New Jersey court rule requiring the release of certain details regarding outside funding backers. The law is designed to address the growing calls for regulation of litigation funders. J&J is facing more than 60,000 claims when you add up state and federal Baby Powder lawsuits. Third-party funding in mass tort claims has pros and pros and. There is no doubt that we are witnessing how third-party funding could level the playing field between individuals as well as large corporations in the courtroom.

April 4 2023 Update: It’s enjoyable to see the worm turn in this case. J&J was hit again this week, when an appeals court in the Third Circuit denied J&J’s request to extend the automatic stay while J&J appeals a bankruptcy ruling to the U.S. Supreme Court. Automatic stays have froze hundreds of cases involving talcum powder and stopped new lawsuits from getting filed ever since J&J started the controversial process to spin the talc liabilities into a bankrupt subsidiary more than a year back. Johnson & Johnson infant tylenol settlement. After the 3rd Circuit ruled that this bankruptcy was invalid only a few months back, the stay was removed. J&J had hoped to have it continued pending its SCOTUS appeal. But, no.
April 1st, 2023 Update Johnson & Johnson announced it will appeal its 3rd Circuit bankruptcy loss to the U.S. Supreme Court last week. There is a chance that the Supreme Court is willing even to take up the appeal? Low.
March 16th 2023 Update: with the bankruptcy stay fully lifted, the first new cases were filed and incorporated into the class action for talcum powder MDL in over one year. Seven new talc-related lawsuits were brought into the MDL in the last month and brought the total number of pending cases up to 37,522.

February 25, 2023 Update 2023 Update: A Congressmen from Tennessee has now demanded that authorities from the U.S. Government Accountability Office (GAO) initiate an investigation into the cost J&J Talc products have cost the government in the many years.
in a letter addressed to the GAO, Rep. Steven Cohen (D-Ten.) claimed that J&J of ignoring the dangers of its talc-based products for many years, while tax dollars were used to treat those who were injured through exposure to the chemicals. The suit comes just a few days after J&J’s major loss in the 3rd Circuit Court of Appeals.

Johnson & Johnson infant tylenol settlement. J&J must begin making fair settlement offers to victims to begin to put all of this behind. This is a disgrace to one of the world’s greatest businesses.

February 14 2023 Update: During an appearance today in New Jersey, U.S. Bankruptcy Judge Michael Kaplan announced his intention to follow the third U.S. Circuit Court of Appeals ruling to dismiss the bankruptcy case.

 

You May be Entitled to Significant Compensation Johnson & Johnson infant tylenol settlement. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

 

  • Does Talc Actually Cause Cancer – Are You Eligible To File A Talc Lawsuit?
  • Why Can’t I File For Divorce Online – Cheap Online Divorce Lawyers Near Me
  • Talc Is Dangerous – Are You Eligible To File A Talc Lawsuit?
  • Michigan Divorce Records Online Free – Cheap Online Divorce Lawyers Near Me
  • Divorce Online Franklin County – Cheap Online Divorce Lawyers Near Me
  • Johnson & Johnson Reaches Deal For $8.9 Billion Talc Settlement – Are You Eligible To File A Talc Lawsuit?
  • Dont Get A Divorce, Lady From Florida That Has A Group Online – Cheap Online Divorce Lawyers Near Me
  • Kentucky Divorce Records Online Free – Cheap Online Divorce Lawyers Near Me
  • Free Nh File For Divorce Online – Cheap Online Divorce Lawyers Near Me
  • Free Online Idaho Divorce Papers – Cheap Online Divorce Lawyers Near Me
  •  

  • Contact
  • Disclosure
  • Finding A Good Divorce Lawyer
  • Privacy Policy
  •  

    >>> Johnson & Johnson Infant Tylenol Settlement

    You May Also Like